These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Type III interferon (IFN-lambda) antagonizes the antiviral activity of interferon-alpha in vitro. Bordi L; Lalle E; Lapa D; Caglioti C; Quartu S; Capobianchi MR; Castilletti C J Biol Regul Homeost Agents; 2013; 27(4):1001-9. PubMed ID: 24382181 [TBL] [Abstract][Full Text] [Related]
3. Dengue virus infection induces interferon-lambda1 to facilitate cell migration. Hsu YL; Wang MY; Ho LJ; Lai JH Sci Rep; 2016 Jul; 6():24530. PubMed ID: 27456172 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line. Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855 [TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes. Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983 [TBL] [Abstract][Full Text] [Related]
6. Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication. Suzuki Y; Chin WX; Han Q; Ichiyama K; Lee CH; Eyo ZW; Ebina H; Takahashi H; Takahashi C; Tan BH; Hishiki T; Ohba K; Matsuyama T; Koyanagi Y; Tan YJ; Sawasaki T; Chu JJ; Vasudevan SG; Sano K; Yamamoto N PLoS Pathog; 2016 Jan; 12(1):e1005357. PubMed ID: 26735137 [TBL] [Abstract][Full Text] [Related]
7. Induction of anti-viral genes mediated by humoral factors upon stimulation with Lactococcus lactis strain plasma results in repression of dengue virus replication in vitro. Tsuji R; Yamamoto N; Yamada S; Fujii T; Yamamoto N; Kanauchi O Antiviral Res; 2018 Dec; 160():101-108. PubMed ID: 30393011 [TBL] [Abstract][Full Text] [Related]
8. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses. Yu JS; Tseng CK; Lin CK; Hsu YC; Wu YH; Hsieh CL; Lee JC Antiviral Res; 2017 Jan; 137():49-57. PubMed ID: 27847245 [TBL] [Abstract][Full Text] [Related]
9. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124 [TBL] [Abstract][Full Text] [Related]
10. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. Chen HW; King K; Tu J; Sanchez M; Luster AD; Shresta S J Immunol; 2013 Oct; 191(8):4194-201. PubMed ID: 24043884 [TBL] [Abstract][Full Text] [Related]
11. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1. Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543 [TBL] [Abstract][Full Text] [Related]
12. SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Brand S; Zitzmann K; Dambacher J; Beigel F; Olszak T; Vlotides G; Eichhorst ST; Göke B; Diepolder H; Auernhammer CJ Biochem Biophys Res Commun; 2005 Jun; 331(2):543-8. PubMed ID: 15850793 [TBL] [Abstract][Full Text] [Related]
13. High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue. Simon-Loriere E; Lin RJ; Kalayanarooj SM; Chuansumrit A; Casademont I; Lin SY; Yu HP; Lert-Itthiporn W; Chaiyaratana W; Tangthawornchaikul N; Tangnararatchakit K; Vasanawathana S; Chang BL; Suriyaphol P; Yoksan S; Malasit P; Despres P; Paul R; Lin YL; Sakuntabhai A J Infect Dis; 2015 Dec; 212(12):2011-20. PubMed ID: 26063222 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection. Zainal N; Chang CP; Cheng YL; Wu YW; Anderson R; Wan SW; Chen CL; Ho TS; AbuBakar S; Lin YS Sci Rep; 2017 Feb; 7():42998. PubMed ID: 28216632 [TBL] [Abstract][Full Text] [Related]
15. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway. Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050 [TBL] [Abstract][Full Text] [Related]
16. Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses. Clarke JN; Davies LK; Calvert JK; Gliddon BL; Shujari WHA; Aloia AL; Helbig KJ; Beard MR; Pitson SM; Carr JM J Gen Virol; 2016 Jan; 97(1):95-109. PubMed ID: 26541871 [TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy. Huang X; Yue Y; Li D; Zhao Y; Qiu L; Chen J; Pan Y; Xi J; Wang X; Sun Q; Li Q Sci Rep; 2016 Feb; 6():22303. PubMed ID: 26923481 [TBL] [Abstract][Full Text] [Related]
18. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM). Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736 [TBL] [Abstract][Full Text] [Related]
19. Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication. Kao YS; Wang LC; Chang PC; Lin HM; Lin YS; Yu CY; Chen CC; Lin CF; Yeh TM; Wan SW; Wang JR; Ho TS; Chu CC; Zhang BC; Chang CP PLoS Pathog; 2023 Mar; 19(3):e1011241. PubMed ID: 36930690 [TBL] [Abstract][Full Text] [Related]
20. DDX50 inhibits the replication of dengue virus 2 by upregulating IFN-β production. Han P; Ye W; Lv X; Ma H; Weng D; Dong Y; Cheng L; Chen H; Zhang L; Xu Z; Lei Y; Zhang F Arch Virol; 2017 Jun; 162(6):1487-1494. PubMed ID: 28181036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]